Clinical Trials on Metastatic Neuroendocrine Neoplasm
Total 107789 results
-
University of Massachusetts, WorcesterCompleted
-
Yale UniversityNovartisTerminatedMetastatic MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompleted
-
California Pacific Medical Center Research InstituteCompletedMetastatic MelanomaUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
M.D. Anderson Cancer CenterAventis PharmaceuticalsCompleted
-
Molecular Insight Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
Pain TherapeuticsCompleted
-
Peking UniversityNovartisCompletedMetastatic MelanomaChina
-
Charite University, Berlin, GermanyUnknown
-
University of TurkuCompletedMetastatic MelanomaFinland
-
Groupe Oncologie Radiotherapie Tete et CouGustave Roussy, Cancer Campus, Grand ParisCompletedSquamous Cell Head and Neck Carcinoma | Recurrent or Metastatic DiseaseFrance, Belgium
-
California Pacific Medical Center Research InstituteM.D. Anderson Cancer CenterRecruitingMetastatic MelanomaUnited States
-
California Pacific Medical Center Research InstituteTesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer InstituteRecruitingMetastatic MelanomaUnited States
-
PrimeVax Immuno-Oncology Inc.Not yet recruitingMetastatic Melanoma
-
Inge Marie SvaneRecruitingMetastatic MelanomaDenmark
-
Hoffmann-La RocheCompletedMetastatic MelanomaUnited States, Canada, Belgium, Spain, France, Russian Federation, Australia
-
Idera Pharmaceuticals, Inc.CompletedMetastatic MelanomaUnited States
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.Completed
-
University of LouisvilleJames Graham Brown Cancer CenterActive, not recruitingMetastatic MelanomaUnited States
-
Saint John's Cancer InstituteTerminatedMetastatic MelanomaUnited States
-
Eisai Inc.CompletedMetastatic MelanomaUnited States, Australia, United Kingdom, Germany
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMetastatic MelanomaUnited States
-
Novartis PharmaceuticalsCompletedMetastatic MelanomaSwitzerland, United States
-
AB ScienceTerminatedMetastatic MelanomaFrance, Spain, Italy, United States, Czechia, Germany, Russian Federation
-
Aduro Biotech, Inc.Terminated
-
Inge Marie SvaneCompleted
-
Hoffmann-La RocheCompleted
-
Walter J. StorkusNational Cancer Institute (NCI)Completed
-
University of California, IrvineTerminatedMetastatic MelanomaUnited States
-
University Hospital, MontpellierSaint-Louis Hospital, Paris, FranceCompleted
-
Cliniques universitaires Saint-Luc- Université...Terminated
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
John P. FruehaufBayerCompletedMetastatic MelanomaUnited States
-
American Regent, Inc.Completed
-
Western Regional Medical CenterWithdrawnMetastatic MelanomaUnited States
-
John KirkwoodNational Cancer Institute (NCI); National Institutes of Health (NIH)Terminated
-
University of IowaNovartis Pharmaceuticals; Holden Comprehensive Cancer CenterTerminatedMetastatic MelanomaUnited States
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi CompanyCompletedMetastatic MelanomaUnited States
-
University of ZurichCompleted
-
University of PittsburghBristol-Myers SquibbWithdrawn
-
Italian Network for Tumor Biotherapy FoundationAstex Pharmaceuticals, Inc.Unknown
-
Hadassah Medical OrganizationCompletedMetastatic MelanomaIsrael
-
Ludwig Institute for Cancer ResearchAgonOxWithdrawn
-
California Pacific Medical Center Research InstitutePfizer; University of California, San FranciscoCompleted
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
University of ChicagoCompletedMetastatic MelanomaUnited States
-
Providence Health & ServicesWithdrawn
-
Sheba Medical CenterUnknownMetastatic MelanomaIsrael
-
Myrexis Inc.Completed